Cholecystokinin receptor type A — Drug Target
All drugs that target Cholecystokinin receptor type A — marketed and clinical-stage. Includes 3 drug classes acting on this target.
Drug classes
ceruletide · Cholecystokinin Analog [EPC] · dexloxiglumide
Marketed (2)
- Caerulein · ceruletide · Gastroenterology
- Sincalide · Bracco · Cholecystokinin Analog [EPC] · Gastroenterology
Sincalide works by binding to cholecystokinin receptors in the pancreas, stimulating the release of digestive enzymes.
Phase 3 pipeline (1)
- D-Loxiglumide · dexloxiglumide · Gastroenterology
Dexloxiglumide works by binding to the cholecystokinin receptor type A, which is involved in regulating digestive processes.